S News

Stocks

S News

Headlines

Headlines

Cleveland-Cliffs, Albemarle & SentinelOne: Emerging Stock Picks

Amidst the tech focus, Cleveland-Cliffs, Albemarle, and SentinelOne are brands to watch. Institutional confidence in Cleveland-Cliffs is rising due to tariffs increasing domestic demand, while Albemarle shows significant EPS growth potential. SentinelOne's bullish outlook is also gaining attention.

Date: 
AI Rating:   7

Market Sentiment and Institutional Backing

The report highlights how certain stocks are undervalued due to market focus shifting towards technology and AI sectors. Specifically, Cleveland-Cliffs Inc. (CLF) has garnered the interest of institutional investors with a significant increase in holdings, reflecting growing confidence in its potential for stock price increases. This confidence is attributed to rising demand for domestic products driven by recent trade tariffs.

Cleveland-Cliffs Overview

As institutional buyers bolster their holdings in Cleveland-Cliffs stock, currently valued at approximately $199.7 million with a 4.3% ownership stake, strong signs of market confidence are evident. The report notes expectations of a price target of $16.7 per share for Cleveland-Cliffs, indicating potential upside of up to 50%. Such valuation suggests a good risk-to-reward scenario for investors.

Albemarle's Positive EPS Growth

Albemarle Co. (ALB) is projected to experience considerable growth driven by anticipated earnings per share (EPS) of $2.18 in the second quarter of 2025, reversing from a net loss. This expected EPS growth is crucial as earnings growth typically drives stock price increases. Additionally, the report indicates a current consensus price target of $109.7 per share for Albemarle, implying a potential rally of 35.4% from current levels.

SentinelOne's Bullish Outlook

For SentinelOne Inc. (S), analysts have initiated coverage with a positive outlook despite its current undervaluation as it trades at 75% of its 52-week high. The recommendation for an outperform rating and a price target set at $32 per share represents a significant upside of 46.2%, indicating growing institutional interest and investor speculation on future performance.